Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 May 6;9(13):3102-3113.
doi: 10.12998/wjcc.v9.i13.3102.

Sarcomatoid carcinoma of the pancreas - multimodality imaging findings with serial imaging follow-up: A case report and review of literature

Affiliations
Case Reports

Sarcomatoid carcinoma of the pancreas - multimodality imaging findings with serial imaging follow-up: A case report and review of literature

Hyun Jae Lim et al. World J Clin Cases. .

Abstract

Background: Sarcomatoid carcinoma of the pancreas is extremely rare and has an extremely poor prognosis. Although a few cases of sarcomatoid carcinoma of pancreas have been reported, most are focused on a histopathological review. To the best of our knowledge, there are no reports documenting multimodality imaging characteristics and chronological changes with emphasis on radiologic features.

Case summary: A 64-year-old woman was admitted to Chungnam National University Hospital with acute appendicitis. Contrast-enhanced computed tomography of the abdomen revealed a 2.6 cm × 2.8 cm multilobular cystic mass in the pancreatic tail. The pancreatic lesion showed suspected mural nodules and thin septa. Hence, mucinous cystic neoplasm of pancreas was considered. After 7 mo, the patient was readmitted for repeated epigastric abdominal pain and nausea. Follow-up contrast-enhanced computed tomography of the abdomen and magnetic resonance imaging revealed a marked enlargement (5.4 cm × 4 cm), with a predominant internal solid component. The mass showed low signal intensity on a T1-weighted image and heterogeneously intermediate high signal intensity on a T2-weighted image. It showed diffusion restriction and peripheral rim enhancement on an arterial phase image, and progressive enhancement on portal venous and delayed phase images. Distal pancreatectomy was performed. Based on the morphology and immunohistochemical staining of the specimen, pancreatic sarcomatoid carcinoma was diagnosed.

Conclusion: We present the computed tomography, magnetic resonance imaging, and positron emission tomography computed tomography findings, pathologic features, and chronological changes for preoperative diagnosis.

Keywords: Carcinosarcoma; Case report; Computed tomography; Magnetic resonance imaging; Pancreas; Pancreatectomy.

PubMed Disclaimer

Conflict of interest statement

Conflict-of-interest statement: The authors declare that they have no conflict of interest.

Figures

Figure 1
Figure 1
Initial computed tomography imaging of the abdomen. A and B: Axial portal venous phase computed tomography images showing a 2.6 cm × 2.8 cm multilobulated cystic mass with an eccentric, relatively thick contrast-enhancing wall, and eccentric coarse calcification in the pancreatic body (orange arrows). No main pancreatic duct dilatation is observed. Upstream of the pancreatic parenchyma showed markedly atrophic changes, and the obliterated splenic vein was replaced with tortuous splenorenal collaterals (blue arrows).
Figure 2
Figure 2
Follow-up computed tomography imaging 7 mo later. A and B: A non-contrast image (A), and a portal venous phase image (B) showing a pancreatic cystic mass, 5.4 cm × 4 cm in size, involving the pancreatic tail with a large solid component (arrows) in the rapidly growing cystic lesion. A portal venous phase image showing heterogeneous enhancement of the solid part of the mass (B).
Figure 3
Figure 3
Magnetic resonance imaging findings. A-D: An axial T2-weighted image showed an intermediate-to-high-signal intensity (SI) solid mass with peripheral cystic lesions in the pancreatic body (A); the solid portion in the mass showed diffusion restriction on the diffusion-weighted image (B); an apparent diffusion coefficient map (C); a small amount of intra-tumoral hemorrhage (arrow), showing high SI on an axial T1-weighted image (D) and low SI on a T2-weighted image was noted in the peripheral cystic portion (A); E-G: Axial contrast-enhanced dynamic T1-weighted images demonstrated significant peripheral progressive enhancement of the central solid portion.
Figure 4
Figure 4
Positron emission tomography-computed tomography imaging findings. Positron emission tomography-computed tomography showed a lobulated mass with intense 18-Fluorodeoxyglucose uptake in the pancreatic body. No evidence of distant metastasis was identified.
Figure 5
Figure 5
Histological examination of the lesion. A: Microscopically, the tumor consisted of a central solid portion (arrow) and a thickened peripheral cystic wall (asterisk) on hematoxylin and eosin staining (magnification, × 40). Pathological findings showed that the tumors were adjacent to each other as two different components: sarcomatoid carcinoma (arrow) and mucinous cystic neoplasm (MCN) with high-grade dysplasia (asterisk); B and C: The MCN components were strongly and diffusely positive for pan-cytokeratin on immunostaining (magnification, × 200). The sarcomatoid carcinoma components were weakly positive for pan-cytokeratin (B) but strongly positive for vimentin on immunostaining (magnification, × 200) (C); D and E: The MCN had an ovarian-like stroma, which was immunohistochemically positive for the estrogen receptor (D), and the progesterone receptor (E) (magnification, × 200, respectively).
Figure 6
Figure 6
Serial postoperative follow-up computed tomography imaging. A: Postoperative follow-up computed tomography after 1 mo showed multiple small hepatic metastases; B: After chemotherapy, the lesion reduced in size; C: However, new metastatic lesions had developed by the 7 mo follow-up, as seen in the computed tomography image.

Similar articles

Cited by

References

    1. Li J, Wei T, Zhang J, Wei S, Chen Q, Chen BW, Zhou Y, Wen L, Qin H, Bai X, Liang T. Carcinosarcoma of the pancreas: comprehensive clinicopathological and molecular characterization. HPB (Oxford) 2020;22:1590–1595. - PubMed
    1. World Health Organization. WHO classification of tumours: digestive system tumors. 5th ed. Genève, Switzerland: World Health Organization, 2019: 328-329.
    1. Van JD, Snoeks T. Carcinosarcoma of the body of the pancreas. Acta Gastro-enterologica Belgica. 1951;14:106–113. - PubMed
    1. Alhatem A, Quinn PL, Xia W, Chokshi RJ. Pancreatic Carcinosarcoma Clinical Outcome Analysis of the National Cancer Institute Database. J Surg Res. 2021;259:62–70. - PubMed
    1. Virmani V, Khandelwal A, Sethi V, Fraser-Hill M, Fasih N, Kielar A. Neoplastic stomach lesions and their mimickers: spectrum of imaging manifestations. Cancer Imaging. 2012;12:269–278. - PMC - PubMed

Publication types

LinkOut - more resources